Jennifer Levin Carter

Founder and CEO

2023 - Current

Medzown is Precision Medicine Management at Scale. We use advanced analytics and deep expertise to bridge the gap between patients and treatments like immunotherapies, targeted therapies, cell and gene therapies, and clinical trials. At the same time, we deliver exceptional return on investment for payers, providers, and pharma.

Founder and CEO

2023

Venture Partner

2021

Sandbox invests in technologies that drive lasting change in human livelihood and transform healthcare, sustainability and insurance & financial services. Sandbox also provides innovation consulting through Sandbox Advisors. Sandbox Clinical Ventures focuses on accelerating clinical innovation by investing in companies with transformative diagnostic, device and lab technologies. We bring together key stakeholders across the strategic and investment landscape to back companies that can improve the health of populations, reimagine the experience of care, and bend the cost curve.

Senior Strategic Advisor

2020

Co-founder, Board Member

2019

Board of Directors

2018

Member, Directors Advisory Board

2013

Board Member, Board Of Directors

2020 - 2023

Managing Director

2021 - 2023

The Blue Venture Fund is a unique collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association (BCBSA), and Sandbox, to which thirty-five BCBS companies have committed approximately $900 million across four funds. The Blue Venture Fund invests in promising emerging companies of strategic relevance to Blue Cross and/or Blue Shield companies and provides the portfolio with access to BCBS companies to deploy innovation at scale.  Sandbox is an independent company that provides healthcare-related investment management exclusively for the Blue Venture Fund.

Board Member and Senior Advisor

2020 - 2022

Acquired by InTandem